| Mrs Jaclyn Golus Mentzer, PA | |
|
388 E. Parkcenter Blvd. Gem State Dermatology, Boise, ID 83706 | |
| (208) 424-9101 | |
| (208) 424-5072 |
| Full Name | Mrs Jaclyn Golus Mentzer |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 16 Years |
| Location | 388 E. Parkcenter Blvd. Gem State Dermatology, Boise, Idaho |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487899365 | NPI | - | NPPES |
| 808380800 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | M7247 (Idaho) | Secondary |
| 363A00000X | Physician Assistant | PA773 (Idaho) | Secondary |
| 363A00000X | Physician Assistant | PA-773 (Idaho) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gem State Dermatology Pa | 6901700269 | 5 |
News Archive
In the first year after the Accreditation Council for Graduate Medical Education (ACGME) reduced the number of continuous hours that residents can work, there was no change in the rate of death or readmission among hospitalized Medicare patients, according to a new study published in JAMA.
Southern Nevada residents in need of emergency medical care for a stroke may benefit from a Mayo Clinic "telestroke" program that is now available at all three campuses of Dignity Health-St. Rose Dominican (Rose de Lima, Siena and San Martín).
Individuals with new-onset type 1 diabetes who took two courses of alefacept (Amevive®, Astellas Pharma Inc.) soon after diagnosis show preserved beta cell function after two years compared to those who received a placebo.
With infectious diseases, it is often not the pathogen itself, but rather an excessive inflammatory immune responses death, for instance as a result of organ damage. On intensive care units, sepsis is the second-most common cause of death worldwide. In patients with a severely compromised immune system specially, life-threatening candida fungal infections represent a high risk of sepsis.
Fractional flow reserve (FFR)-guided drug-eluting stenting reduces death, myocardial infarction or urgent revascularisation, as compared to medical therapy in patients with stable coronary artery disease (CAD), according to the results of the FAME 2 trial presented for the first time today at ESC Congress by principal investigator Dr Bernard De Bruyne (Belgium).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jaclyn Golus Mentzer, PA 388 E. Parkcenter Blvd. Gem State Dermatology, Boise, ID 83706 Ph: (208) 424-9101 | Mrs Jaclyn Golus Mentzer, PA 388 E. Parkcenter Blvd. Gem State Dermatology, Boise, ID 83706 Ph: (208) 424-9101 |
News Archive
In the first year after the Accreditation Council for Graduate Medical Education (ACGME) reduced the number of continuous hours that residents can work, there was no change in the rate of death or readmission among hospitalized Medicare patients, according to a new study published in JAMA.
Southern Nevada residents in need of emergency medical care for a stroke may benefit from a Mayo Clinic "telestroke" program that is now available at all three campuses of Dignity Health-St. Rose Dominican (Rose de Lima, Siena and San Martín).
Individuals with new-onset type 1 diabetes who took two courses of alefacept (Amevive®, Astellas Pharma Inc.) soon after diagnosis show preserved beta cell function after two years compared to those who received a placebo.
With infectious diseases, it is often not the pathogen itself, but rather an excessive inflammatory immune responses death, for instance as a result of organ damage. On intensive care units, sepsis is the second-most common cause of death worldwide. In patients with a severely compromised immune system specially, life-threatening candida fungal infections represent a high risk of sepsis.
Fractional flow reserve (FFR)-guided drug-eluting stenting reduces death, myocardial infarction or urgent revascularisation, as compared to medical therapy in patients with stable coronary artery disease (CAD), according to the results of the FAME 2 trial presented for the first time today at ESC Congress by principal investigator Dr Bernard De Bruyne (Belgium).
› Verified 5 days ago